NHS cancer services and systems—ten pressure points a UK cancer control plan needs to address

In this Policy Review we discuss ten key pressure points in the NHS in the delivery of cancer care services that need to be urgently addressed by a comprehensive national cancer control plan. These pressure points cover areas such as increasing workforce capacity and its productivity, delivering eff...

Full description

Saved in:
Bibliographic Details
Published in:The lancet oncology Vol. 25; no. 8; pp. e363 - e373
Main Authors: Aggarwal, Ajay, Simcock, Richard, Price, Pat, Rachet, Bernard, Lyratzopoulos, Georgios, Walker, Kate, Spencer, Katie, Roques, Tom, Sullivan, Richard
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01.08.2024
Elsevier Limited
Subjects:
Cancer
Cancer therapies
Colorectal cancer
Delivery of Health Care
Hematology, Oncology, and Palliative Medicine
Humans
Medical diagnosis
Medical prognosis
Medical research
Medical screening
Minority & ethnic groups
Multiculturalism & pluralism
Neoplasms - therapy
Pandemics
Patients
Planning
Population
Prostate cancer
Quality of Health Care
Quality of life
Sociodemographics
State Medicine - organization & administration
Survival
United Kingdom
Young adults
United Kingdom
United Kingdom > UK
England
ISSN:1470-2045, 1474-5488, 1474-5488
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In this Policy Review we discuss ten key pressure points in the NHS in the delivery of cancer care services that need to be urgently addressed by a comprehensive national cancer control plan. These pressure points cover areas such as increasing workforce capacity and its productivity, delivering effective cancer survivorship services, addressing variation in quality, fixing the reimbursement system for cancer care, and balancing of the cancer research agenda. These areas have been selected based on their relative importance to ensuring sustainable cancer services, persistence as key issues in the NHS, and their impact on delivering better and more equitable and affordable patient outcomes. Many of these pressure points are not acknowledged explicitly in any current discourse. The evidence we provide points to their impact on the ability to deliver world class cancer care, but also to their amenability to affordable solutions if given the relevant prioritisation and investment. The current narrative needs to move away from a technocentric approach to improving care, to one focused on understanding the complexity of cancer services and the wider health system to drive improvements in survival, quality of life, and experience for patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:1470-2045
1474-5488
1474-5488
DOI:10.1016/S1470-2045(24)00345-0